Strategic partnerships Opportunity to leverage CBR’s network of partner organizations and diversity of collaborations to cross-sell complementary services or co-develop initiatives with institutions that already align with CBR’s clinical trial focus and stem cell applications.

Clinical trial leverage Sales approach could emphasize access to FDA-regulated trials and exclusive pathways for participating families, positioning related biobanking or research services as a value-added gateway for research institutions seeking high-quality cord blood and tissue samples.

Family-centric branding Capitalize on CBR’s trust with OB/GYNs and expecting parents by offering extended education programs, referral incentives, and white-labeled patient-facing materials to drive adoption of CBR storage and related services among new families.

Technology enablement Highlight the tech stack and data capabilities to potential clients, proposing integrated analytics, consent management, and personalized outreach solutions to streamline study recruitment, donor tracking, and regulatory compliance.

Growth runway With a strong revenue profile and historical acquisitions context, pursue partnerships with mid-market fertility, neonatal research, or biotech firms for joint ventures, licensing, or scalable storage/processing capacity to support expanding cord blood and tissue needs.